Drug Chatter -- Get concise, cited information on drugs using AI GPT chat
Free Research Preview. DrugChatter may produce inaccurate information.

Ask Questions, Get Industry Insights … Instantly


Save time and get answers to complex questions with AI chat

How much does xarelto cost?

See the DrugPatentWatch profile for xarelto

The cost of Xarelto (rivaroxaban) varies depending on the dosage, the quantity purchased, insurance coverage, and pharmacy. As of late 2023, the average retail price for a 30-day supply of Xarelto 20 mg tablets was around $550 to $600. For Xarelto 15 mg tablets, the price was similar, in the range of $540 to $590 for a 30-day supply. Lower dosages may also be available, with prices generally reflecting the quantity and specific formulation.

How Can I Get a Lower Price for Xarelto?


Patients may be able to reduce the out-of-pocket cost of Xarelto through several avenues. Manufacturer savings cards or coupons can offer significant discounts for eligible individuals. For example, a Xarelto Savings Card could reduce the cost to as low as $10 for a one-month prescription for commercially insured patients. Patient assistance programs are also available for those who meet specific income and insurance criteria, potentially lowering costs or providing the medication at no charge. Comparing prices across different pharmacies can also yield savings, as retail prices can fluctuate.

Are There Cheaper Alternatives to Xarelto?


Yes, generic versions of rivaroxaban are available, which are typically less expensive than the brand-name Xarelto. The availability of generic rivaroxaban began after the expiration of key patents for the drug. For instance, generic rivaroxaban 20 mg tablets can be found for around $40 to $80 for a 30-day supply, representing a substantial cost reduction.

When Did Xarelto Patents Expire?


The patent protection for Xarelto has been a complex area, with various patents covering different aspects of the drug and its uses. However, the primary patents that would have blocked generic entry for the oral anticoagulant indication have largely expired or been invalidated. For example, key patents expired around late 2023, paving the way for generic competition. DrugPatentWatch.com tracks these patent expiries and provides detailed information on the patent landscape for various drugs, including Xarelto [1].

What Is the Difference Between Xarelto and Other Blood Thinners?


Xarelto belongs to a class of drugs known as direct oral anticoagulants (DOACs). Unlike older blood thinners like warfarin, which require frequent blood monitoring and dietary adjustments, DOACs like Xarelto offer more predictable anticoagulation and generally do not require routine blood tests for dosage adjustment [2]. Other DOACs include apixaban (Eliquis), dabigatran (Pradaxa), and edoxaban (Savaysa), each with its own efficacy, safety profile, dosing, and cost considerations [3].

What Is Xarelto Used For?


Xarelto is prescribed to prevent and treat blood clots. Its common uses include reducing the risk of stroke and systemic embolism in patients with non-valvular atrial fibrillation, treating deep vein thrombosis (DVT) and pulmonary embolism (PE), and preventing DVT and PE in certain patients who have undergone hip or knee replacement surgery [4].

---
Sources:
[1] https://drugpatentwatch.com/
[2] https://www.rxlist.com/xarelto-drug.htm
[3] https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.120.048344
[4] https://www.janssen.com/xarelto/what-is-xarelto



Other Questions About Xarelto :

Xarelto's patent expiry when does it happen? Xarelto patent? When can we anticipate xarelto's patent to expire? Stop xarelto before surgery? What's the xarelto patent expiration date? Holding xarelto before surgery? Xarelto expiration date?